Since the establishment of Unitech Medical, Inc. in 2005, we have considered our employees the number one asset of the company. Each team member is a talented, honest, creative and hardworking individual.
Each carries an integral piece of the company's foundation to focus on the health of all. Unitech Medical integrates each team member’s practical experience and scientific knowledge into the development of exceptional natural solutions.
The Company’s close collaboration within the medical industry further strengthens and increases availability of innovative healthcare products with the highest quality.
Traditional Chinese Medicine Advisory Board
Hongsheng Lin, M.D.
Dr. Lin is Chair of the Oncology Department at Guang’anmen Hospital in Beijing. It is a national TCM Center of Cancer approved by the State Administration Bureau of TCM. It is also a clinical pharmacological research base of Chinese herbs, a part of the Traditional Medicine Cooperative Center organized by WHO (World Health Organization), a training base for doctors of Western Medicine who want to learn TCM, and a clinical teaching hospital associated with four medical colleges. Dr. Lin is also the president of the Specialty Committee of Oncology, Chinese Association of Integrative Medicine (CAIM), and the Specialty Committee of Traditional Medicine, Chinese Anti-Cancer Association (CACA). Moreover, she is an editorial board member of a number of academic journals, and was awarded the state's highest honor in recognition of her national and international medical accomplishments. Dr. Lin has been actively involved in basic, clinical cancer research. She has over 30 years of experience in conducting clinic cancer research with the goal of enhancing clinical activity and reducing the toxicity associated with chemotherapy, and has had continuous funding from the National Key Technology R&D Program for performance of medicine therapeutic schedule to improve the median survival time of NSCLC. Her research made the point that "FUZHENGPEIBEN" should be the main treatment principle for cancer patients. Her basic research interests have focused on the characterization of the molecular mechanisms of Fuzheng herbs, especially the mechanism on regulation of immune function. Over the past few years she established international cooperation on the research of Chinese medicine between Guang’anmen Hospital, the China Academy of Chinese Medicine Sciences and the National Cancer Institute. She is the key architect of the International Consortium of Chinese Medicine and Cancer.
Dr. Lin has authored and coauthored over 150 peer-reviewed publications and book chapters in the areas of Chinese medicine and cancer. She authored national guidelines in treatment of cancer using TCM. According to her distinguished research achievement, she has received multiple awards, including the second-class award of Science and Technology Progress of China Academy of Chinese Medical Sciences, the first-class award of Science and Technology Progress of China Society of Integrated Traditional Chinese and Western Medicine, the first-class award of Science and Technology Progress of China Association of Chinese Medicine, and the first-class award of Science and Technology Progress of China Society of Integrated Traditional Chinese and Western Medicine.
Mengda Shu, OMD, L.Ac.
Originating from Beijing, China, Dr. Shu is a Doctor of Traditional Chinese Medicine as well as a Licensed Acupuncturist, practicing in Washington, D.C. She was nominated as one of the top acupuncturists and herbalists in the D.C. area by the Washingtonian Magazine.
Dr. Shu received her doctoral degree from the Medical School of the China Academy of Traditional Chinese Medicine, one of the top medical schools in China. Dr. Shu finished her postdoctoral studies in herbology and acupuncture under the guidance of China's leading physicians. Dr. Shu worked at Guang'anmen Hospital and taught acupuncture at the Beijing College of Acupuncture and Orthopedics.
Since her arrival in the United States in 1992, Dr. Shu has been in private practice at her Georgetown office in Washington, D.C. Her pracitce is associated with the Taoist Health Institute which was founded by Dr. Wu, the Taoist scholar, author and translator of Yi Jing (Book of Changes), Ling Shu (the Spiritual Pivot) and An Illustrated Chinese Materia Medica. Dr. Shu also assisted Dr. Wu in developing a classic Chinese herbal formula as an alternative to hormone replacement therapy in menopause, which is the first herbal formula that is NIH-sponsored and FDA-approved.
Dr. Shu is a member of the Center for Integrative Medicine at George Washington University Medical Center since 1997. She also teaches TCM to the medical professionals at GWU.
Dr. Shu frequently speaks at major medical conferences and organizations, such as the National Museum of Health and Medicine, the Ohio Medical College, the Maryland Acupuncture School. Dr. Shu has written articles for the Journal of Traditional Chinese Medicine, and authored the Handbook of the Oriental Medical Doctor.